Announcements Trials
Browse Landscape

Phase

Phase 1 5

Status

Completed 4Terminated 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Advanced Solid Tumors 5Solid Tumors 2Solid Tumor 1Carcinoma, Non-Small-Cell Lung 1Advanced or Metastatic Solid Tumors 1

Interventions

Injections 18Carboplatin 14Docetaxel 11pembrolizumab 8durvalumab 7Cisplatin 6linifanib 5Paclitaxel 5Nivolumab 5zimberelimab 4talazoparib 4olaparib 4Panobinostat 4Itraconazole 4Bevacizumab 4tremelimumab 3sintilimab 3depatuxizumab 3atezolizumab 3ST 1481 3S 1 (combination) 3Rifampin 3Pemetrexed 3Oxaliplatin 3Fluorouracil 3Everolimus 3Drug Therapy 3trifluridine tipiracil drug combination 2trametinib 2toripalimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Advanced Solid Tumors × linifanib × Clear all
NCT00733187 2017-11-21

Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869

AbbVie

Phase 1 Completed
34 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT01413893 2017-11-21

An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors

AbbVie

Phase 1 Completed
35 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT01286974 2012-09-21

A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors.

Abbott

Phase 1 Terminated
3 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT01381341 2012-03-23

To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib.

Abbott

Phase 1 Completed
13 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT01401933 2011-11-02

Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors

Abbott

Phase 1 Completed
14 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡